INNOVATIVE CLINICAL SOLUTIONS LTD
- CIK: 0001002022
- EIN: 65-0617076
- Business address: 10 DORRANCE ST, STE 400, PROVIDENCE, Rhode Island, 02903
Information
Mailing address
10 DORRANCE STREET, SUITE 400, PROVIDENCE, Delaware, 02903Phone
4018316755State location
Rhode IslandState of incorporation
DelawareFiscal year end
January 31SIC
8011 - (CF Office: Office of Life Sciences) SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINEFilings
N/A
About INNOVATIVE CLINICAL SOLUTIONS LTD
INNOVATIVE CLINICAL SOLUTIONS LTD (CIK: 0001002022) is an American company incorporated in the state of Rhode Island. Head office is located at 10 DORRANCE ST, STE 400, PROVIDENCE, Rhode Island, 02903. Work in the industry 8011 - (CF Office: Office of Life Sciences) SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE. INNOVATIVE CLINICAL SOLUTIONS LTD is a public company and trade via Over-The-Counter (OTC).Old names:
- PHYMATRIX CORP from 1996-18-Jun to 1999-11-Jun
Ownership
Updating!
Stock Chart
Coming soon!
Jobs
Coming soon!
Recent SEC Filings
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by INNOVATIVE CLINICAL SOLUTIONS LTD
| Filings | Format | Description | Filed/Effective | File/Film Number |
|---|---|---|---|---|
| 15-15D | Document | Notice of suspension of duty to file reports pursuant to Section 13 and 15(d) of the Act Acc-no: 0000914260-03-000027 ( Act) Size: 4 KB |
Feb-14-2003 | 03563569 |
| SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001132072-03-000023 ( Act) Size: 12 KB |
Feb-12-2003 | 03553268 |
| SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001099281-03-000041 ( Act) Size: 9 KB |
Jan-31-2003 | 03533241 |
| 8-K | Document | Current report filing Acc-no: 0000914260-03-000008 ( Act) Size: 27 KB |
Jan-21-2003 | 03519802 |
| 8-K | Document | Current report filing Acc-no: 0000914260-02-000065 ( Act) Size: 26 KB |
Sep-23-2002 | 02770104 |
| 8-K/A | Document | Amendment to Current report filing Acc-no: 0000914260-02-000060 ( Act) Size: 8 KB |
Aug-15-2002 | 02739550 |
| 8-K | Document | Current report filing Acc-no: 0000914260-02-000058 ( Act) Size: 8 KB |
Aug-07-2002 | 02721389 |
| SC 13D | Document | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0000912057-02-023837 ( Act) Size: 60 KB |
Jun-11-2002 | 02676719 |
| 10-K | Document | Annual report pursuant to section 13 and 15(d) Acc-no: 0000912057-02-023293 ( Act) Size: 360 KB |
Jun-06-2002 | 02672322 |
| SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001099281-02-000144 ( Act) Size: 18 KB |
Jun-05-2002 | 02671212 |
| NT 10-K | Document | Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10KT Acc-no: 0000914260-02-000041 ( Act) Size: 7 KB |
May-01-2002 | 02630126 |
| 8-K | Document | Current report filing Acc-no: 0000914260-02-000037 ( Act) Size: 5 KB |
Mar-22-2002 | 02582055 |
| SC 13G | Document | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001132072-02-000056 ( Act) Size: 12 KB |
Feb-27-2002 | 02560744 |
| 8-K | Document | Current report filing Acc-no: 0000914260-02-000027 ( Act) Size: 67 KB |
Feb-20-2002 | 02554475 |
| 8-K | Document | Current report filing Acc-no: 0000914260-02-000009 ( Act) Size: 7 KB |
Jan-28-2002 | 02518523 |
| SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001099281-02-000010 ( Act) Size: 17 KB |
Jan-10-2002 | 2505769 |
| DEFA14C | Document | Definitive additional information statement materials including Rule 14(a)(12) material Acc-no: 0000912057-02-000825 ( Act) Size: 340 KB |
Jan-09-2002 | 2505258 |
| 10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000912057-01-544469 ( Act) Size: 124 KB |
Dec-21-2001 | 1822003 |
| NT 10-Q | Document | Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB Acc-no: 0000914260-01-500027 ( Act) Size: 7 KB |
Dec-17-2001 | 1815553 |
| DEF 14C | Document | Definitive information statements Acc-no: 0000912057-01-542731 ( Act) Size: 1325 KB |
Dec-11-2001 | 1811043 |
Recent 20 filings. View all INNOVATIVE CLINICAL SOLUTIONS LTD filings
Reviews
Ryan Storey
Huge help thank you for your help .. y'all make it so much easier
Jean Bishop
Very good communication and delivery made within the timeframe I was advised of
Catherine
Thanks I look forward to using the product to improve my skin tone
Frequently Asked Questions
Tags:
- INNOVATIVE CLINICAL SOLUTIONS LTD overview
- INNOVATIVE CLINICAL SOLUTIONS LTD job
- INNOVATIVE CLINICAL SOLUTIONS LTD stock
- INNOVATIVE CLINICAL SOLUTIONS LTD ownership
- INNOVATIVE CLINICAL SOLUTIONS LTD CEO
- INNOVATIVE CLINICAL SOLUTIONS LTD documents
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
Orther Companies
ETAO International Co., Ltd.
Update: Dec 16, 2022
WOOD DONALD S PHD
Update: Aug 25, 2022
WHITE CLAUDE E
Update: Aug 25, 2022
US MEDICAL GROUP INC
Update: Aug 24, 2022
U S PHYSICIANS INC
Update: Aug 24, 2022
Teladoc Health, Inc.
Update: Aug 23, 2022
Latest News
SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate...
Charter Communications to Pay $25 Million Penalty for Unauthorized...
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries...
SEC Charges Royal Bank of Canada with Internal Accounting Controls...
SEC Charges President/CCO of Prophecy Asset Management Advisory...
SEC Adopts Rules for the Registration and Regulation of Security-Based...
SEC Charges Crypto Company SafeMoon and its Executive Team for...
© 2022 